US-based premium pet nutrition brand Nulo has officially entered the United Kingdom market, calling the move an important “milestone”...
Read MoreGenfit has announced encouraging preliminary findings from a phase 1b clinical trial evaluating its investigational therapy, GNS561, in combination...
Read MoreFinnish biotechnology company NADMED has announced the launch of the NADMED Award 2026, positioning it as a catalyst for...
Read MoreTitle21 Health Solutions, a portfolio company specialising in life science regulatory support, has joined the Blood and Cells Advocacy...
Read MoreRichmond Sausages is preparing to expand its meat-free portfolio with the launch of a new sub-range, Richmond Veggie Tasty,...
Read MoreSobi has entered into an agreement to acquire Arthrosi Therapeutics, a private late-stage biotechnology company focused on developing a...
Read More